U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07705126) titled 'A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC' on July 09.
Brief Summary: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes symptoms such as bloody diarrhea, abdominal pain, and frequent bowel movements. It can significantly affect patients' quality of life. Etrasimod is an oral medication taken once daily that has been shown in clinical trials to be effective for treating active UC. However, clinical trial results may not fully reflect how the drug works in real-world clinical practice, where patients have more diverse backgrounds and medical conditions.
This is a ...